REVIVA PHARMACEUTICALS HOLDINGS, INC. - RVPH

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 30, 2026 SCHEDULE 13G Integrated Core Strategies (US) LLC 6.2% 793,952 View
Mar 30, 2026 SCHEDULE 13G Millennium Management LLC 6.2% 793,952 View
Mar 30, 2026 SCHEDULE 13G Millennium Group Management LLC 6.2% 793,952 View
Mar 30, 2026 SCHEDULE 13G Israel A. Englander 6.2% 793,952 View
Mar 25, 2026 SCHEDULE 13G CVI Investments, Inc. 5.2% 666,667 View
Mar 25, 2026 SCHEDULE 13G Heights Capital Management, Inc. 5.2% 666,667 View
Mar 24, 2026 SCHEDULE 13D/A 2.8% View
Feb 17, 2026 SCHEDULE 13G/A 683 CAPITAL MANAGEMENT, LLC 3.0% 3,492,500 View
Feb 17, 2026 SCHEDULE 13G/A 683 CAPITAL PARTNERS, LP 3.0% 3,492,500 View
Feb 17, 2026 SCHEDULE 13G/A Zweiman Ari 3.0% 3,492,500 View
Jan 16, 2026 SCHEDULE 13G/A Integrated Core Strategies (US) LLC 2.8% 3,254,631 View
Jan 16, 2026 SCHEDULE 13G/A Millennium Management LLC 2.8% 3,257,670 View
Jan 16, 2026 SCHEDULE 13G/A Millennium Group Management LLC 2.8% 3,257,670 View
Jan 16, 2026 SCHEDULE 13G/A Israel A. Englander 2.8% 3,257,670 View
Dec 22, 2025 SCHEDULE 13D/A 4.4% 689,150 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.